Description:

 Anti-Rabies Immunoglobulin (ARIG) is a passive immunization used to prevent rabies infection after exposure.

Dosage Form: 

Injection (Liquid)

Strength:

– 300 IU/mL (International Units per milliliter)

Active Ingredients:

– Human Rabies Immunoglobulin (HRIG)

Indications:

– Post-exposure prophylaxis (PEP) against rabies

– Prevention of rabies infection after bite or exposure

Contraindications:

– Hypersensitivity to HRIG or human immunoglobulins

– Severe thrombocytopenia

– History of allergic reactions to HRIG

Side Effects: 

Rarely:

– Pain, redness, swelling at injection site

– Headache

– Fatigue

– Allergic reactions (anaphylaxis)

Precautions:

– Administer under medical supervision

– Monitor for allergic reactions

– Avoid repeated doses

Prescription/OTC:

 Prescription

Manufacturer Information:

– Name: Various (e.g., Sanofi Pasteur, GlaxoSmithKline)

– Reputation: Reputable

Country of Origin: 

Various (e.g., US, France, Belgium)

Category of Drug:

 Passive Immunization, Immunoglobulin

Storage: 

Store at 2-8°C (36-46°F).

Dosage:

– 20 IU/kg body weight, administered once

Regulatory Approval:

– FDA-approved (US)

– EMA-approved (EU)

– WHO-prequalified